Institutional Fund
M28 Capital Management LP
Stamford, CTCIK 18074895 filings on record
Portfolio Value
$53.80M
Q1 2026
Holdings
9
Reported positions
New Buys
0
Opened this quarter
QoQ Change
-60.9%
from $137.57M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Wave Life Sciences Ltd61.8%
- Invivyd Inc22.3%
- Tg Therapeutics Inc5.5%
- Arrowhead Pharmaceuticals In4.3%
- Proqr Thrapeutics N V1.8%
- Fractyl Health Inc1.6%
- Other2.7%
Portfolio Holdings
9 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Wave Life Sciences Ltd | 4.59M | $33.27M | 61.8% | −1.08M | Reduced |
| 2 | Invivyd Inc | 9.25M | $12.02M | 22.3% | 0 | Held |
| 3 | Tg Therapeutics Inc | 88.4K | $2.94M | 5.5% | −73.2K | Reduced |
| 4 | Arrowhead Pharmaceuticals In | 36.9K | $2.31M | 4.3% | −30.5K | Reduced |
| 5 | Proqr Thrapeutics N V | 599.8K | $971.7K | 1.8% | −419.7K | Reduced |
| 6 | Fractyl Health Inc | 1.86M | $849.7K | 1.6% | 0 | Held |
| 7 | Rocket Pharmaceuticals Inc | 210.9K | $754.9K | 1.4% | −174.8K | Reduced |
| 8 | Silence Therapeutics PLC | 101.2K | $533.3K | 1.0% | −83.9K | Reduced |
| 9 | Curis Inc | 284.9K | $155.9K | 0.3% | −236.2K | Reduced |